P21~(wafl) and Vascular Endothelial Growth Factor Expression in Non-Small-cell Lung Cancer and Their Clinical Relation

YI Xiang-hua

2003-01-01

Abstract:Objective To study the expression of p21WAFI and vascular endothelial growth factor (VEGF) and intratumoral microvessel density (MVD) in non-small cell lung cancer (NSCLC), and their clinical significances. Methods The specimens of lung biopsy by bronchoscopy and chest wall from 45 patients suffered from NSCLC were stained immunohistochemically for p21 and VEGF expression. MVD was calculated by labeling the endothelial cells of the blood vessels with CD31 antibody within the tumor tissue. Results p21WAFI and VEGF expression were found in 31 and 35 patients (68.9% and 77.8%) respectively; p21WAFI , VEGF expression and MVD were not significantly correlated with sex, pathological histology (P 0.05), while p21 and VEGF expression were closely correlated with the clinical stage and MVD. The survival of patients with p21WAFI-positive and VEGF-negative expression was not significantly higher than that with p21WAFI -negative and VEGF-positive expression (P0.05). The survival of patients with p21WAFI and VEGF-positive expression wasn't significantly higher than that with p21WAFI and VEGF-negative expression (P 0.05). Conclusions p21WAFI and VEGF play a key role in occurrence and development of NSCLC and serve as indicators of malignancy and development of NSCLC. Nuclear p21WAFI accumulation may associate with tumor angiogenesis through VEGF up-regulation. VEGF expression contributes to the tumor neovascularization and tumor metastasis.